Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-017-1777-y
Published Online: 2017-02-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Busard, C. I.
Menting, S. P.
van Bezooijen, J. S.
van den Reek, J. M.
Hutten, B. A.
Prens, E. P.
de Jong, E. M.
van Doorn, M. B.
Spuls, P. I.